Pfizer’s comments on its timeline raise the possibility of US authorisation of a coronavirus vaccine this year. Photo: Reuters
In blow to Donald Trump’s campaign, Pfizer will not seek authorisation for coronavirus vaccine until after US election
- Pfizer said the company may know whether its vaccine is effective by the end of October, but won‘t have the safety data until the end of November
- Move is a final blow to Donald Trump’s repeated pledges to make a vaccine available before Americans cast votes
Pfizer’s comments on its timeline raise the possibility of US authorisation of a coronavirus vaccine this year. Photo: Reuters
